Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | thiocolchicoside | 5430 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | thiocolchicoside | 5430 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | thiocolchicoside | 5430 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mesoridazine | 4078 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | mesoridazine | 4078 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | mesoridazine | 4078 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | mesoridazine | 4078 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | mesoridazine | 4078 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | mesoridazine | 4078 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mesoridazine | 4078 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | mesoridazine | 4078 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | imatinib | 5291 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | imatinib | 5291 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | imatinib | 5291 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | imatinib | 5291 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | imatinib | 5291 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | imatinib | 5291 | drug-path |
Asthma | R-HSA-444620 | map05310 | imatinib | 5291 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | imatinib | 5291 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | imatinib | 5291 | drug-path |